Release Date: 26/11/15 11:13 Summary: Initial Director's Interest Notice Price Sensitive: No Download Document 218.74KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%